Comparison of Two Circular-Stapled Techniques for Esophageal Cancer: A Propensity-Matched Analysis

The optimal technique for the thoracoscopic construction of an intrathoracic esophagogastric anastomosis continues to be a subject of controversy. The aim of this study was to compare the perioperative outcomes of circular-stapled anastomosis using a transorally inserted anvil (Orvil™) with those of...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2021-12, Vol.11, p.759599-759599
Main Authors: Lin, Hang, Liang, Ge'ao, Chai, Huiping, Liao, Yongde, Zhang, Chunfang, Cheng, Yuanda
Format: Article
Language:English
Subjects:
anastomotic leakage
anastomotic technique
esophageal cancer
minimally invasive Ivor Lewis esophagectomy
Oncology
thoracoscopic intrathoracic esophagogastric anastomosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The optimal technique for the thoracoscopic construction of an intrathoracic esophagogastric anastomosis continues to be a subject of controversy. The aim of this study was to compare the perioperative outcomes of circular-stapled anastomosis using a transorally inserted anvil (Orvil™) with those of circular-stapled anastomosis using a transthoracically placed anvil (non-Orvil™) in totally minimally invasive Ivor Lewis esophagectomy (Ivor Lewis TMIE). The data of 272 patients who underwent Ivor Lewis TMIE for esophageal cancer at multiple centers were collected from January 1, 2014 to December 31, 2017. After propensity score matching (1:1) for patient baseline characteristics, 65 paired cases were selected for statistical analysis. Logistic regression analysis was performed to investigate the significant factors of anastomotic leakage. In the propensity score-matched analysis, compared with the non-Orvil™ group, the Orvil™ group was associated with a significantly shorter operation time ( =0.031), less intraoperative hemorrhage (
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.759599